Recombinant Human IL-29 Protein

A DNA sequence encoding the Human IL-29 Protein(Q8IU54)(1-200)was expressed with a polyhistidine tag at the N-terminus.

Introducing the Recombinant Human IL-29 Protein, a cutting-edge biotechnological advancement in the field of immunology. This highly purified and bioactive protein is meticulously engineered to exhibit exceptional potency and efficacy in various therapeutic applications.

The Recombinant Human IL-29 Protein is derived from a state-of-the-art recombinant DNA technology, ensuring its utmost purity and consistency. With its molecular weight of approximately 20 kDa, this protein is meticulously manufactured to meet the highest industry standards, guaranteeing its exceptional quality and reliability.

This innovative product showcases remarkable immunomodulatory properties, making it an invaluable tool in the study and treatment of various immune-related disorders. The Recombinant Human IL-29 Protein has been extensively researched and proven to possess potent antiviral activity, particularly against certain strains of viruses. Its ability to induce the production of antiviral proteins and enhance the immune response against viral infections has garnered significant attention from the scientific community.

Furthermore, the Recombinant Human IL-29 Protein exhibits promising therapeutic potential in the treatment of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Its ability to regulate the immune system and modulate inflammatory responses has shown great promise in preclinical studies, paving the way for potential breakthroughs in the field of immunotherapy.

With its exceptional purity, potency, and bioactivity, the Recombinant Human IL-29 Protein is an indispensable tool for researchers and clinicians alike. Its consistent quality and reliable performance make it an ideal choice for a wide range of applications, including in vitro studies, animal model experiments, and potential therapeutic interventions.

In conclusion, the Recombinant Human IL-29 Protein represents a remarkable advancement in the field of immunology. Its exceptional purity, potent immunomodulatory properties, and promising therapeutic potential make it an invaluable asset in the pursuit of understanding and treating immune-related disorders.